Skip to content
OpenCapital
Get started

Achieve Life Sciences ACHV Other Assets And Restricted Cash

Other financials

Income statement

See full
Net income-$10.2M+20.7%
EPS (diluted)-$0.19+48.6%

Balance sheet

See full
Cash & equivalents$28.1M+116%
Total debt$5.6M+332%
Total equity$10.7M+3.9%
Total assets$33.1M+21.0%

Cash flow

See full
Operating cash flow-$6.9M+37.5%
CapEx$750.0—
Free cash flow-$12.4M—

Valuation

See full
Market cap$585.16M+404%
Enterprise value$562.71M+439%

Returns & leverage

See full
Return on equity-496.1%-906pp
Debt / equity0.5×+0.4×
Current ratio2.6×-0.9×

Where this comes from

Reported directly by Achieve Life Sciences in its filing.

Tagged under the XBRL concept achv:OtherAssetsAndRestrictedCash.

The official record: Achieve Life Sciences’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Achieve Life Sciences's other assets and restricted cash.

Connect your AI assistant and see it in context, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Achieve Life Sciences's other assets and restricted cash?
Achieve Life Sciences (ACHV) reported other assets and restricted cash of $265K in Q1 2026.
How has Achieve Life Sciences's other assets and restricted cash changed year-over-year?
Achieve Life Sciences's other assets and restricted cash decreased by 11.7% year-over-year, from $300K to $265K.
What is the long-term trend for Achieve Life Sciences's other assets and restricted cash?
Over 5 years (2020 to 2025), Achieve Life Sciences's other assets and restricted cash has grown at a -28.5% compound annual growth rate (CAGR), from $279K to $52K.